Observational, Passive Surveillance Program to Collect Information on Women and Their Offspring Exposed to MenQuadfi® During Pregnancy, in United States (US)

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

March 5, 2021

Primary Completion Date

May 18, 2028

Study Completion Date

May 18, 2028

Conditions

Meningococcal Infection

Interventions

BIOLOGICAL

Meningococcal polysaccharide (serogroups A, C, Y, and W) tetanus toxoid conjugate vaccine

Pharmaceutical form: Solution for injection Route of administration: Intramuscular

Trial Locations (1)

RECRUITING

Pennsylvania Locations, Swiftwater

All Listed Sponsors

lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY